SYNCHROCYCLOTRON PRELIMINARY DESIGN FOR A DUAL HADRONTHERAPY CENTER

The Italian research foundation TERA has proposed an innovative accelerator solution, called “Cyclinac” [1], dedicated to hadrontherapy, the technique of tumor radiotherapy which employs ion beams, in particular protons and carbon ions. It is composed of a fixed-energy cyclotron injecting into a variable-energy linac. This paper describes the preliminary design of a dedicated superconducting synchrocyclotron providing fast cycling (400 Hz) beams of 230 MeV/u C6+ and H2 + (Kbending = 920 MeV)

Cyclotron Designs for Ion Beam Therapy with Cyclinacs

This thesis presents new superconducting compact (as opposed to separated-sector ) cyclotron designs for injection in CABOTO, a linac developed by the TERA Foundation delivering C6+/H2+ beams up to 400 MeV/u for ion beam therapy. This association of a variable energy linac injected by a fixed energy cyclotron is called cyclinac. Two superconducting cyclotron designs are compared under the same design constraints and methods: a synchrocyclotron and an isochronous cyclotron, both at the highest possible magnetic field and with an output energy of 230 MeV/u. This energy allows to use the cyclotron as a stand-alone accelerator for protontherapy. Once the optimal cyclotron is determined, lower energy cyclotrons can easily be designed. The short pulse length (1.5 µs), fast repetition rate (100-300 Hz) and small beam transmission of the cyclinac (0.2%) require intense pulsed ion sources. To deliver the desired clinical dose rate, the average pulse current of 60 eµA of C6+ at 300 Hz can be produced by three commercial EBIS (EBIS-SC by Dreebit Gmbh) operating at 100 Hz and connected to the beamline in alternating mode. A multicusp ion source is sufficient to produce compatible H2+ beams. The synchrocyclotron design features a central magnetic field of 5 T, an axisymmetric pole and a constant field index of 0.02. The beam is injected axially with a spiral inflector (K = 1.4). A static magnetic perturbation of 0.1 T and 5° width boosts the beam radial gain per turn (with no emittance degradation) by exciting the first radial integer resonance and thus allows beam ejection with moderate beam losses (30%). The RF system operates in first harmonic (Q = 2500). The 180° Dee provides 28 kV peak voltage and the RF is modulated (30-38 MHz) by a rotating capacitor (90-900 pF). The synchrocyclotron's best features are the simple and compact magnet (300 tons) and the low RF power requirements (30 kW power supply). The isochronous cyclotron design features a 3.2 T central magnetic field, four sectors and a pole characterized by elliptical gaps in the hills (3-30 mm) and in the valleys (11-50 cm). Spiraling is minimized (80° total hill axis rotation) and beam ejection is achieved with a single electrostatic deflector placed inside an empty valley. The two RF cavities operate in fourth harmonic at 98 MHz (Q = 7100). The RF system provides peak voltages of 70-120 kV and is powered by a single 100 kW unit. The synchrocyclotron reliability is brought into question by the need of a rotating capacitor and by the complexity of the injection and ejection systems. However, the isochronous cyclotron requires a much more complex magnet. Overall, the isochronous cyclotron is a better solution compared to the synchrocyclotron, because it is as compact but more reliable. To quantitatively determine the industrial and clinical optimum for the CABOTO injection energy, three complementary isochronous cyclotrons of 70, 120 and 170 MeV/u are studied, based on the 230 MeV/u design. The optimal cyclotron energy strongly depends on the clinical aim of the facility. For a dual proton and carbon ion centre, the best compromise between clinical flexibility, accelerator size and power consumption is to accelerate particles up to 150 MeV/u in the cyclotron. In this configuration, the 150 MeV/u isochronous cyclotron has similar weight and spiraling as the most widely used cyclotron for protontherapy (C235 by IBA S.A.), CABOTO is 24 m long and the overall power consumption of the cyclinac is 650 kW. Adding to these characteristics, the property of fast energy variation of the linac makes the cyclinac presented in this thesis a strongly competitive accelerator for dual proton and carbon ion therapy

High-Gradient Test of a 3 GHz Single-Cell Cavity

Pro­ton and car­bon ion beams pre­sent ad­van­ta­geous depth-dose dis­tri­bu­tions with re­spect to X-rays. Car­bon ions allow a bet­ter con­trol of "ra­diore­sis­tant" tu­mours due to their high­er bi­o­log­i­cal re­sponse. For deep-seat­ed tu­mours pro­ton and car­bon ion beams of some nA and en­er­gies of about 200 MeV and 400 MeV/u re­spec­tive­ly are need­ed. For these ap­pli­ca­tions TERA pro­posed the "cy­clinac": a high-fre­quen­cy linac which boosts the hadrons ac­cel­er­at­ed by a cy­clotron. The di­men­sions of the com­plex can be re­duced if high­er ac­cel­er­at­ing gra­di­ents are achieved in the linac. To test the max­i­mum achiev­able fields, a 3 GHz cav­i­ty has been built by TERA. The 19 mm-long cell is fore­seen to be ex­cit­ed at 200 Hz by 3 us RF puls­es and should reach a 40 MV/m ac­cel­er­at­ing gra­di­ent, which cor­re­sponds to a peak sur­face elec­tric field Es of 260 MV/m. In a first high-pow­er test per­formed at CTF3 the cell was op­er­at­ed at 50 Hz with a max­i­mum peak power of 1 MW. The max­i­mum Es achieved was above 350 MV/m. The break­down rate at these field val­ues was around 10-1 bpp/m. The max­i­mum value of the mod­i­fied Poynt­ing vec­tor is close to the best val­ues achieved by high gra­di­ent struc­tures at 12 and 30 GHz

Tomography of Horizontal Phase Space Distribution of a Slow Extracted Proton Beam in the MedAustron High Energy Beam Transfer Line

MedAustron is a synchrotron based hadron therapy and research center in Wiener Neustadt, Austria, which currently is under commissioning for the first patient treatment. The High Energy Beam Transfer Line (HEBT) consists of mul- tiple functional modules amongst which the phase-shifter- stepper PSS is the most important module located where the dispersion from the synchrotron is zero and upstream of the switching magnet to the first irradiation room. The PSS is used to control the beam size for the downstream modules and for this scope rotates the beam in horizontal phase space by adjusting the phase advance. This functionality is used in this study to measure beam profiles for multiple phase space angles which act as input for a tomographic reconstruction. Simulation and measurement results are presented

Feasibility study for a biomedical experimental facility based on LEIR at CERN

In light of the recent European developments in ion beam therapy, there is a strong interest from the biomedical research community to have more access to clinically relevant beams. Beamtime for pre-clinical studies is currently very limited and a new dedicated facility would allow extensive research into the radiobiological mechanisms of ion beam radiation and the development of more refined techniques of dosimetry and imaging. This basic research would support the current clinical efforts of the new treatment centres in Europe (for example HIT, CNAO and MedAustron). This paper presents first investigations on the feasibility of an experimental biomedical facility based on the CERN Low Energy Ion Ring LEIR accelerator. Such a new facility could provide beams of light ions (from protons to neon ions) in a collaborative and cost-effective way, since it would rely partly on CERN’s competences and infrastructure. The main technical challenges linked to the implementation of a slow extraction scheme for LEIR and to the design of the experimental beamlines are described and first solutions presented. These include introducing new extraction septa into one of the straight sections of the synchrotron, changing the power supply configuration of the magnets, and designing a new horizontal beamline suitable for clinical beam energies, and a low-energy vertical beamline for particular radiobiological experiments

The Mechanical Environment Modulates Intracellular Calcium Oscillation Activities of Myofibroblasts

Myofibroblast contraction is fundamental in the excessive tissue remodeling that is characteristic of fibrotic tissue contractures. Tissue remodeling during development of fibrosis leads to gradually increasing stiffness of the extracellular matrix. We propose that this increased stiffness positively feeds back on the contractile activities of myofibroblasts. We have previously shown that cycles of contraction directly correlate with periodic intracellular calcium oscillations in cultured myofibroblasts. We analyze cytosolic calcium dynamics using fluorescent calcium indicators to evaluate the possible impact of mechanical stress on myofibroblast contractile activity. To modulate extracellular mechanics, we seeded primary rat subcutaneous myofibroblasts on silicone substrates and into collagen gels of different elastic modulus. We modulated cell stress by cell growth on differently adhesive culture substrates, by restricting cell spreading area on micro-printed adhesive islands, and depolymerizing actin with Cytochalasin D. In general, calcium oscillation frequencies in myofibroblasts increased with increasing mechanical challenge. These results provide new insight on how changing mechanical conditions for myofibroblasts are encoded in calcium oscillations and possibly explain how reparative cells adapt their contractile behavior to the stresses occurring in normal and pathological tissue repair

Coupling of Cyclotrons to Linacs for Medical Applications

Cyclotron and Linac technologies cover the vast majority of accelerator solutions applied to medicine. Cyclotrons with beams of H+/H-around 20 MeV are found for radioisotope production and cyclotrons with beams up to 250 MeV are widely used for protontherapy. Linacs are present in every medium-sized hospital with electron beams up to 20 MeV for radiotherapy and radioimaging. They have also recently become available as commercial products for protontherapy. The coupling of these two strong technologies enables to expand the capabilities of cyclotrons by using linacs as boosters. This opens the way to innovative accelerator systems allowing both radioisotope production and ion beam therapy (cyclinacs), new treatment techniques (high energy protontherapy) and new imaging techniques (proton radiography). This paper provides an overview of the technical challenges linked to coupling cyclotrons to linacs and the various solutions at hand

Beam parameters optimization and characterization for a TUrning LInac for Protontherapy

TULIP (TUrning LInac for Protontherapy) is a novel compact accelerator system for protontherapy mounted on a rotating gantry (Amaldi et al., 2013, 2010, 2009). Its high-energy Linac has the unique property of being able to modulate the beam energy from one pulse to the next, in only a couple of milliseconds. The main purpose of this study is to optimize the properties of the beam exiting the Linac to make them compatible to medical therapy and to characterize their medical physics properties for later implementation in a Treatment Planning System. For this purpose, multi-particle tracking and Monte Carlo (MC) simulations are used to follow the particles through their path up to the treatment isocenter, following the so-called phase-space method. The data compiled includes particle fluences in air and depth-dose curves and provides the basis for a specific model of the TULIP beam